Ekso Bionics (EKSO) Misses Q4 EPS by 5c

Ekso Bionics (NASDAQ: EKSO) reported Q4 EPS of ($0.14), $0.05 worse than the analyst estimate of ($0.09). Revenue for the quarter came in at $5.1 million versus the consensus estimate of $6.05 million.

For earnings history and earnings-related data on Ekso Bionics (EKSO) click here.

You May Also Be Interested In

• Walmart (WMT) PT Lowered to $130 at UBS on Investment Narrative's Competing Dynamics
• MGE Energy (MGEE) Declares $0.5083 Quarterly Dividend; 2.6% Yield
• Beike (BEKE) PT Raised to $23 at Morgan Stanley